Our reports help you make sense of the prescription drugs market.
In an effort to keep our clients in the know, WellDyneRx publishes a biannual drug pipeline report.
Each report contains:
- Descriptions of newly approved drugs, including product highlights, place in therapy, and market impact.
- Summaries of specialty, non-specialty, biosimilar, and generic drugs with anticipated FDA approval dates in the upcoming 12 months.
- Additional FDA actions, including rejections and indications for specific drugs.
Explore the latest below.
In addition, WellDyneRx also publishes a yearly Drug Trend Report. This provides an in-depth look at U.S. prescription drug costs, examines how they’re being utilized, and explores any factors that could influence the future of the marketplace.